-
Featured ArticleSeptember 11, 2023Personalizing pediatric cancer research
Professor Ching Lau envisions a world where his pediatric cancer patients receive targeted medicines with minimal side effects. -
Research HighlightDecember 13, 2021Examining the immune response to cancer on a genetic level
The V Foundation for Cancer Research has awarded a grant to JAX's Lucas Chang for genetic studies of the immune response to cancer. -
Blog PostNovember 18, 2020Revealing treatment options with category variants
-
Blog PostAugust 12, 2020JAX Diversity Outbred Mice: A Genetically Diverse Mouse for a Diverse Human Population
-
Featured ArticleSeptember 15, 2022JAX undertakes nationwide study to evaluate impact of genomic tumor boards on cancer care
The Jackson Laboratory announced today that it will take its cornerstone genomic tumor board program to oncologists across the nation as part of a SWOG Cancer Research Network study, in collaboration with Columbia University. -
Blog PostJanuary 20, 2021Advancing Humanized NSG Mice for Immuno-Oncology Testing
Immunologically humanized NSGTM and its variant strains are a powerful system that facilitates cutting-edge in vivo preclinical testing of a wide range of immuno-oncology therapeutic candidates. -
Research HighlightAugust 18, 2020Using genetic variability for better cancer therapies
Muneer Hasham is working to improve the odds of success in one of the most difficult drug development areas of all: cancer. -
Blog PostJuly 21, 2020Why humanized mice?
If you read about biomedical breakthroughs, you are hearing more and more about “humanized” mice. But, what is a humanized mouse and why on earth would scientists want to experiment in this way?